INTRODUCTION: Out of pocket (OOP) costs add to the burden facing breast cancer survivors but remain an understudied area of costs. Current turbulent economic climate increases the urgency to better understand this burden. Few studies or systematic reviews focus on OOP costs. METHODS: PubMed search was conducted for articles in English containing: (1) MESH terms breast neoplasms and economics, and (2) words "breast cancer" and "cost" or "costs," "expenditure," or "out of pocket." Limits included: publication dates from January 1, 1980 to December 16, 2009, and populations aged > or = 45 years old. Articles were excluded based on title, abstract, and full text reviews. Citation searches and searches of reference lists were also conducted. Three articles were selected for this review. RESULTS: Medical direct OOP costs (e.g., for physician fees) ranged from $300 to $1,180 per month during active treatment, and were about $500 per month 1 year post diagnosis. Non-medical direct OOP costs (e.g., for transportation to doctor's office, parking etc.) ranged from $137 to $174 per month in the year post diagnosis; and $200-$509 per month 1 year or more after diagnosis. Different types of costs were identified. CONCLUSION: OOP costs represent a significant burden for survivors even after initial treatment. The nature and extent of OOP costs need further evaluation. IMPLICATIONS FOR CANCER SURVIVORS: OOP costs are rarely considered. However, as OOP costs affect the well being of cancer survivors, they should be understood more fully and possibly addressed in interventions aimed at improving quality of life.
INTRODUCTION: Out of pocket (OOP) costs add to the burden facing breast cancer survivors but remain an understudied area of costs. Current turbulent economic climate increases the urgency to better understand this burden. Few studies or systematic reviews focus on OOP costs. METHODS: PubMed search was conducted for articles in English containing: (1) MESH terms breast neoplasms and economics, and (2) words "breast cancer" and "cost" or "costs," "expenditure," or "out of pocket." Limits included: publication dates from January 1, 1980 to December 16, 2009, and populations aged > or = 45 years old. Articles were excluded based on title, abstract, and full text reviews. Citation searches and searches of reference lists were also conducted. Three articles were selected for this review. RESULTS: Medical direct OOP costs (e.g., for physician fees) ranged from $300 to $1,180 per month during active treatment, and were about $500 per month 1 year post diagnosis. Non-medical direct OOP costs (e.g., for transportation to doctor's office, parking etc.) ranged from $137 to $174 per month in the year post diagnosis; and $200-$509 per month 1 year or more after diagnosis. Different types of costs were identified. CONCLUSION: OOP costs represent a significant burden for survivors even after initial treatment. The nature and extent of OOP costs need further evaluation. IMPLICATIONS FOR CANCER SURVIVORS: OOP costs are rarely considered. However, as OOP costs affect the well being of cancer survivors, they should be understood more fully and possibly addressed in interventions aimed at improving quality of life.
Authors: Kenneth M Langa; A Mark Fendrick; Michael E Chernew; Mohammed U Kabeto; Kerry L Paisley; James A Hayman Journal: Value Health Date: 2004 Mar-Apr Impact factor: 5.725
Authors: Ahsan M Arozullah; Elizabeth A Calhoun; Michael Wolf; Denise K Finley; Karen A Fitzner; Elizabeth A Heckinger; Nicolle S Gorby; Glen T Schumock; Charles L Bennett Journal: J Support Oncol Date: 2004 May-Jun
Authors: Sophie Lauzier; Elizabeth Maunsell; Mélanie Drolet; Douglas Coyle; Nicole Hébert-Croteau Journal: Qual Life Res Date: 2010-01-22 Impact factor: 4.147
Authors: Maria Pisu; Andres Azuero; Karen Meneses; Jeffrey Burkhardt; Patrick McNees Journal: Breast Cancer Res Treat Date: 2010-10-26 Impact factor: 4.872
Authors: Alan Ó Céilleachair; Paul Hanly; Máiréad Skally; Eamonn O'Leary; Ciaran O'Neill; Patricia Fitzpatrick; Kanika Kapur; Anthony Staines; Linda Sharp Journal: Support Care Cancer Date: 2017-03-24 Impact factor: 3.603
Authors: Leah M Pyter; Lorena P Suarez-Kelly; William E Carson; Jasskiran Kaur; Joshua Bellisario; Savannah R Bever Journal: Behav Brain Res Date: 2017-05-04 Impact factor: 3.332